1-Deoxy-D-xylulose 5-Phosphate Pathway, Fosmidomycin, Isopentenyl diphosphate, Isoprene, 2-C-Methyl-D-erythritol 4-phosphate Higher plants and several photosynthetic algae contain the plastidic 1-deoxy-D-xylulose 5-phosphate / 2-C-methyl-D-erythritol 4-phosphate pathway (DOXP/MEP pathway) for iso prenoid biosynthesis. The first four enzymes and their genes are known of this novel pathway. All of the ca. 10 enzymes of this isoprenoid pathway are potential targets for new classes of herbicides. Since the DOXP/MEP pathway also occurs in several pathogenic bacteria, such as Mycobacterium tuberculosis, and in the malaria parasite Plasmodium falciparum, all inhibi tors and potential herbicides of the DOXP/MEP pathway in plants are also potential drugs against pathogenic bacteria and the malaria parasite. Plants with their easily to handle DOXP/MEP-pathway are thus very suitable test-systems also for new drugs against patho genic bacteria and the malaria parasite as no particular security measures are required. In fact, the antibiotic herbicide fosmidomycin specifically inhibited not only the D O X P reductoisomerase in plants, but also that in bacteria and in the parasite P. falciparum, and cures malaria-infected mice. This is the first successful application of a herbicide of the novel isoprenoid pathway as a possible drug against malaria.
Introduction
In the last five years the occurrence of a novel non-mevalonate pathway for isoprenoid biosyn thesis in photosynthetic organisms, such as higher plants and algae, as well as in various heterotrophic eubacteria has been established (Lichten thaler, 1999; Rohmer, 1999) . This isoprenoid path way had first been detected in some eubacteria where it is used for the biosynthesis of the sterol surrogates hopanoids and for the side-chain of ubiquinone (Rohmer et al., 1993) . In plants and most algae this DOXP/MEP pathway is responsi ble for the biosynthesis of the plastidic isoprenoids such as carotenoids, phytol (side-chain of chloro phylls), plastoquinone-9, isoprene, as well as mono-and diterpenes (see the review by Lichten thaler, 1999 and references cited therein). This non-mevalonate isoprenoid pathway also occurs in the malaria parasite (Jomaa et al., 1999) and in various pathogenic bacteria, but does not exist in humans or other mammals. This novel pathway opens possibilities for developing new herbicides as well as drugs against pathogenic organisms using plants and their isoprenoid biosynthesis as easy to handle test-systems as is shown here.
The non-mevalonate D O X P /M E P pathway for isoprenoid biosynthesis
In plants the biosynthesis of isopentenyl diphos phate (IPP), the common C5-precursor of all iso prenoids and terpenoids, proceeds via two inde pendent biochemical pathways: 1) The classical acetate/mevalonate pathway is present in the cyto sol and is responsible for the biosynthesis of ste rols, sesquiterpenes and triterpenoids. 2) The alternative, non-mevalonate l-deoxy-D-xylulose-5-phosphate/2-C-methylerythritol 4-phosphate (Lichtenthaler, 1999; Rohmer, 1999) . This non-mevalonate plastidic isoprenoid path way starts with the formation of DOXP from dglyceraldehyde 3-phosphate and pyruvate through the action of the DOXP synthase (Fig. 1) . The next step is the transformation of DOXP into 2-Cmethyl-D-erythritol 4-phosphate (MEP) consisting of a C-C skeletal rearrangement and a reduction step which is catalyzed by the enzyme DOXP reductoisomerase (DXR). The occurrence of this isoprenoid pathway in plants and various photo synthetic algae groups was proven by the incorpo ration of 2 H-and 1 3 C-labeled 1-deoxy-D-xylulose into isoprene and phytol (Schwender et al., 1997; Zeidler et al., 1997) , into ß-carotene and methylerythritol (Arigoni et al., 1997) as well as of radiolabeled DOXP and MEP into ß-carotene by plastid preparations of different plants . The first enzyme of this non-mevalonate isoprenoid pathway, the DOXP synthase (DXS), has been cloned from several higher plants (Lange et al., 1998; Bouvier et al., 1998) , the green alga Chlamydomonas (Lichtenthaler, 1999; Schwender et al., 1999) , E. coli (Sprenger et al., 1997; Lois et al., 1998) and a Streptomyces strain (Kuzuyama et al., 2000a) . The second enzyme of this plastidic IPP pathway, the DOXP reductoisomerase DXR) was recently cloned in the plants Arabidopsis thaliana (Schwender et al., 1999) and Mentha piperita (Lange and Croteau, 1999a) , and also in the eubacterium E. coli . DOXP, made from D-glyceraldehyde 3-phosphate and pyr uvate by the action of DOXP synthase, was readily transformed to MEP by recombinant DOXP re ductoisomerase from Arabidopsis (Schwender et al., 1999) . Fosmidomycin, an antibiotic and herbicidal substance, efficiently inhibits the plants' carotenoid. phytol and isoprene biosynthesis by specifically blocking the DOXP reductoisomerase (Fig. 1) as shown for E. coli and Arabidopsis (Schwender et al., 1999) .
Recently an enzyme from E. coli was described that catalyzes the conversion of MEP to 4-(cytidine 5'-diphospho)-2-C-methylerythritol (CDP-ME) by reaction with CTP (Rohdich et al., 1999) . The corresponding gene, the up to now unanno tated ORF ygbP of E. coli, is also present in the genomes of several micro-organisms and seems to correlate with the occurrence of the DOXP/MEP pathway (Table I) . A gene similar to ygbP carrying a putative plastid transit peptide sequence is also found in A. thaliana. CDP-ME was incorporated into carotenoids by isolated Capsicum chromoplasts (Rohdich et al., 1999) , although one might argue, that it could have been hydrolyzed to MEP before incorporation. The intermediacy of CDP-ME in the DOXP/MEP pathway is, however, sup ported even more convincingly by a study of Ku zuyama et al . (2000b) which showed the CDP-ME synthase encoded by ygbP as essential for IPP bio synthesis in E. coli. The fourth enzyme of the DOXP/MEP pathway, the CDP-ME kinase, was also described recently (Lüttgen et al., 2000) . It phosphorylates CDP-ME at the 2-hydroxy group in an ATP-dependent reaction ( Fig. 1 ) and is en coded by the hitherto unannotated ychB gene of E. coli, which shows the same distribution among bacteria and plants as the genes dxs, dxr and ygbP (Table I ). This CDP-ME kinase is identical with an enzyme recently described as a presumable isopentenyl monophosphate kinase (Lange and Cro teau, 1999b) . Since the latter had only extremely low enzyme activities with isopentenyl monophos phate as a substrate, it is more likely, that ychB is indeed coding for the CDP-ME kinase. The next steps in the biosynthesis of IPP could possibly be the formation of 2-C-methyl-D-erythritol-2,4-cyclodiphosphate ( Fig. 2 ) which is accumulated in several bacteria under oxidative stress conditions (Ostrovsky et al., 1998; Duvold et al., 1997) . Fur ther steps are possibly an intramolecular elimina tion of diphosphate to yield compound 3 followed Table I . Presence of gene sequences of the non-mevalonate isoprenoid pathway in higher plants, apicomplexa (P. falciparum) and in eubacteria. The genes code for the enzymes 1-deoxy-D-xylulose 5-phosphate synthase (dxs), 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr), 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol synthase (ygbP) and 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol 2-phosphate kinase (ychB). The dxs, dxr; ygbP and ychB homologues have not been found in mammals and archaebacteria and do not exist in the complete sequenced genomes of yeast (Saccharomyces cerevisiae) and the nematode Caenorhabditis elegans. Protozoan parasite Plasmodium falciparum 0 9 6 6 9 4 # 0 9 6 6 9 3 # Eubacteria by two reductases and two dehydratases (Fig. 2 ). The resulting IPP is then transformed to its isomer dimethylallyl diphosphate (DMAPP) the starter molecule of isoprenoid biosynthesis to which more IPP molecules are added by head-to-tail conden sation to eventually yield the final isoprenoid. In E. coli the requirement of an IPP/DMAPP isomerase for the formation of DMAPP is, however, questionable (Hahn et al., 1999) , and additional reactions leading to DMAPP therefore cannot be excluded in E. coli.
Organism

The occurrence of the D O X P /M E P pathway in photosynthetic algae and in photosynthetic and heterotrophic bacteria
The DOXP/MEP pathway of IPP and isopren oid formation is generally present in photosyn thetic organisms i.e. higher plants (Lichtenthaler et al., 1997b) , green algae (Lichtenthaler, 1999; Lichtenthaler et al., 1995; Schwender et al., 1996 and Disch et al., 1998) , the red alga Cyanidium, the chrysophyte Ochromonas as well as in the oxygenic photosynthetic blue-green bacteria Sy- , 1999) . The C-atoms 1, 2 and 4 of isopentenyl diphos phate, the first isoprenic C5-unit, come from glyceraldehyde-3-P and the C-atoms 3 and 5 from pyruvate.
nechocystis (Schwender et al., 1997; Disch et al., 1998; Proteau, 1998) and Synechococcus leopoliensis (Miller et al., 1999) . The available data indi cate that during the evolution of algae and higher plants (Lichtenthaler, 1999 ) the photosynthetic eu karyotes have conserved the DOXP/MEP path way which originally had been imported into the eucyte by endosymbiontic cyanobacteria-like pro genitors of the present chloroplasts of algae and higher plants. Genes of the DOXP/MEP pathway are also found in the two photosynthetic bacteria with anoxygenic photosynthesis Rhodobacter and Chlorobium (Table I) . The DOXP/MEP pathway of isoprenoid forma tion is found in many different eubacterial taxo nomic groups, and most eubacteria seem to use it (Rohmer, 1999) . In fact, it was first detected by Rohmer and his group in 1993 during studies of 13 C-incorporation into the bacterial isoprenoid hopanoids (Rohmer et al., 1993) . The eubacteria with the DOXP/MEP pathway of IPP formation, as de duced from 13 C-incorporation of applied 1 3 C-glucose or 13C pyruvate into hopanoids or the prenyl side-chain of ubiquinones, were Zymomonas mobilis, Methylobacterium fujisawaense, Alicylobacillus acidoterrestris and E. coli (Rohmer et al., 1993) .
In several data bases orthologs of the four known genes of IPP formation, dxs, dxr, ygbP (CDP-ME-synthase) and ychB (CDP-ME-kinase) can be found in higher plants as well as in many bacteria including pathogenic bacteria ( Table I ). The following organisms belong to the latter cate gory: Haemophilus influenzae (fever), Mycobacte rium tuberculosis, Mycobacterium leprae (leprosy), Chlamydia trachomatis (urethritis, trachoma, eye disease), Treponema pallidum (syphilis), Helico bacter pylori (gastric ulcer), Vibrio cholerae and Pseudomonas aeruginosa (wound infection). Our database research showed in bacteria, for which the entire genome has been sequenced (e.g. E. coli, Helicobacter pylori, Chlamydia trachomatis as well as the non-pathogenic Bacillus subtilis, Thermotoga maritima, Deinococcus radiodurans), orthologs to dxs, dxr, ygbP and ychB, but no or thologs for the key enzyme of the acetate/mevalonate pathway, the HMG-CoA reductase. In con trast, in completely sequenced Archaebacteria (Pyrococcus horikoshii, Methanococcus jannaschii, Methanobacterium thermo autotrophicum) we found in the database search no orthologs of the four known enzymes of the DOXP/MEP pathway, but only orthologs of HMG-CoA reductase. In most cases only one of the two IPP pathways seemed to appear in a bacterial organism. Helico bacter pylori may be an exception to this rule since its genome also contains a HMG-CoA reductase ortholog.
Due to the strong conservation of the amino acid sequences of the dxs, dxr, ygbP and ychB genes it can be expected that the DOXP/MEP pathway enzymes from plants and pathogenic bac teria share the same enzymic mechanisms and the same binding sites for inhibitors. As a conse quence, it should be possible to control all these pathogenic bacteria by inhibitors of the DOXP/ MEP pathway of IPP formation. In fact, it had been shown already in 1989 that the herbicide fosmidomycin inhibits the isoprenoid biosynthesis in several bacteria (Shigi, 1989) .
O ccurrence of the D O X P /M E P pathway in the malaria parasite P. falciparum Plasmodium falciparum, the parasite causing malaria, is a protozoan organism that possesses a unique plastid-like cell organelle, the apicoplast (McFadden et al., 1997) . The latter with its circular 35-kb genome resembles in many aspects the chloroplasts in algae and plant cells (Köhler et al., 1997) but, being pigment free, does not perform photosynthesis. The apicoplast was apparently ac quired by members of the phylum Apicomplexa by secondary endosymbiosis of an alga, presumably a green alga. The metabolic function of the api coplast is essential for the survival of the parasites (Fichera and Roos, 1997) . Unicellular green algae only possess the plastid-bound DOXP/MEP path way of IPP and isoprenoid formation (Lichten thaler, 1999; Lichtenthaler et al., 1995; Schwender et al., 1996; Disch et al., 1998). Apparently P. falci parum needs the DOXP/MEP pathway of IPP for mation of the apicoplast for its metabolism and replication and seems not to have the mevalonate pathway. In fact, when searching for genes encod ing the enzymes of the DOXP/MEP pathway in P. falciparum a DOXP synthase (DXS) and a DOXP reductoisomerase (DXR) were found which have a great similarity to the corresponding enzymes of bacteria and plants (Jomaa et al., 1999) . This D XR exhibited at the NH2-terminal side a transit pep tide sequence that is typical for targeting the en zyme in plants into the plastid, and in the case of P. falciparum into the apicoplast. The existence of the DOXP/MEP pathway in P. falciparum was fur ther confirmed as the recombinant P. falciparum D X R converted DOXP into MEP (Jomaa et al., 1999) . This then opens up new possibilities to fight against the malaria parasite P. falciparum with in hibitors that specifically block the isoprenoid bio synthesis of the apicoplast (see below).
Inhibition of the D O X P /M E P pathway in plants, bacteria and the malaria parasite
In our search for inhibitors of the plants' DOXP/MEP pathway of IPP and isoprenoid for mation we used two approaches: 1 ) we were look-ing for structural analogues to inhibitors of the plastidic ketol acid reductoisomerase (KARI) which, like the DXR. also catalyzes a C-C skeleton rearrangement followed by an NADPH-dependent reduction step (Lichtenthaler, 1999; and 2) we checked agrochemicals with herbicidal activity (Kamuro et al., 1988; Patterson, 1987) that had been shown to also affect isopren oid biosynthesis in several bacteria (Shigi, 1989) . Fosmidomycin (Fig. 3) proved to be an efficient inhibitor of the plastidic and bacterial isoprenoid biosynthesis Shigi, 1989) , and it specifically blocked the recombinant D X R of E. coli and Arabidopsis Schwender et al., 1999) . Fosmidomycin is a struc tural analogue to 2-C-methylerythrose 4-phos phate (Fig. 3) , the intermediate in the conversion of DOXP to MEP by DXR. In addition it was de monstrated that fosmidomycin and its derivative FR-900098 also block the recombinant D XR of P. falciparum, suppress the growth of multidrug re sistant P. falciparum strains and cure malaria in fected mice (Jomaa et al., 1999) . This is a first ex ample to demonstrate that a herbicidal inhibitor of the DOXP/MEP pathway can also be applied as an antibiotic against pathogenic bacteria as well as an anti-malaria drug. 
Plant test systems for new drugs and inhibitors of the D O X P /M E P pathway
The efficiency of herbicides and antibacterial substances is essentially determined by the uptake rate, the intracellular transport of the active com pound to the enzyme target site and the break down and inactivation processes of the active in gredient. These processes differ in various organisms. Thus, one cannot expect that newly de veloped inhibitor compounds will be equally effec tive in plants, pathogenic bacteria, and the parasite P. falciparum. For the first screening of chemicals as potential inhibitors of the DOXP/MEP pathway of isoprenoid biosynthesis in different organisms plant test-systems are, however, a preferential and first choice. All the precautions during research with pathogenic bacteria and the parasite P. falci parum, such as particular security laboratories or special safety handling of the micro-organisms are not required when working with whole plant testsystems or isolated plant enzymes of the DOXP/ MEP pathway. Once a new structural class of po tential inhibitors/drugs has been detected in plant test-systems, the lead structure and its chemical derivatives can be further tested for maximum efficiency of inhibition in the individual patho genic bacteria and in the parasite P. falciparum. Below some examples of test-systems that have been used by the authors for screening potential new drugs and inhibitors of the DOXP/MEP path way;
Measuring isoprene emission in plant leaves
Many herbaceous plants and leaves of trees pos sess the ability to emit the volatile isoprene. Iso prene is made via the DOXP/MEP pathway (Schwender et al., 1997; Zeidler et al., 1997) from IPP via DMAPP. It is thus a very direct IPP pro duct which requires only two additional enzymes and not as many as in the case of phytol or carotenoids. Thus, further enzymatic steps of plastidic isoprenoid synthesis can be excluded as potential targets by studying the effect of chemicals on iso prene emission. It is emitted by leaves at high irradiances and temperatures above 30 °C. The forma tion of isoprene can easily be studied with a cuvette-test based on the UV absorption of gas eous isoprene in air .
Test with green ripening tomatoes
Injecting the potential chemicals into green rip ening tomatoes, the accumulation of the red carotenoid lycopene will efficiently be suppressed when the active ingredient is an inhibitor of the DOXP/ MEP pathway of IPP formation . This is an easily available test-sytem for vi sual screening.
Light-induced greening o f etiolated barley leaves
A dose-dependent inhibition of carotenoid and chlorophyll accumulation can be tested during the light-induced pigment formation in etiolated leaves as shown for fosmidomycin .
Assays with recombinant enzymes of the DOXP/MEP pathway
In assays with individual enzymes of the DOXP/ MEP pathway all potential inhibitors can be rec ognized by a dose-dependent inhibition of the correponding enzyme product. Assay systems have been developed for the DXS from the green alga Chlamydomonas (Lichtenthaler, 1999; Schwender et al., 1999) , and also for D X R cloned from Arabi dopsis (Schwender et al, 1999) and from E. coli . Others including CDP-ME synthase and CDP-ME kinase of plants are in development.
Besides plant systems, it is also possible to apply non-pathogenic bacteria as test-systems, to which the enzymes of carotenoid biosynthesis have been transferred (Harker and Bramley, 1999) .
Concluding remarks
So far there exists only one inhibitor lead struc ture of the DOXP/MEP pathway of isoprenoid formation, fosmidomycin and its derivatives, which block the DOXP reductoisomerase (DXR). Further targets for potential herbicides, antibiot ics, and drugs are the DOXP synthase (DXS) and the enzymes CDP-ME synthase and the CDP-ME kinase (cf. Fig. 1 ) as well as the other yet unknown enzymes (possibly six) which are required for the transformation of MEP into the final C5 -diphosphate IPP (cf. Figs. 1 and 2) . The fosmidomycin example is a successful transfer of a plant DOXP/ MEP pathway inhibitor to a malaria cure in an animal system, and fosmidomycin can also be used to control bacterial pathogens that possess the DOXP/MEP pathway. This makes the develop ment of new drugs blocking this novel isoprenoid pathway a rewarding task and challenge. Since the DOXP/MEP pathway of IPP formation does not occur in mammals, inhibitors and drugs of this IPP pathway cannot directly affect the isoprenoid me tabolism of humans. The plant test-systems of the DOXP/MEP pathway require no particular safety precautions and are readily available. Plants pro duce various types of plastidic isoprenoids in larger amounts and in a shorter time than bacteria and can thus easily be applied in the search for new herbicides as well as drugs against patho genic microorganisms.
